ABOS
Acumen Pharmaceuticals, Inc.
0.00 (0.00%)2.61USD206K成交股數189M市值–本益比(近四季)14.6股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 4.0M | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 27.8M | 16.5M | 20.5M | 22.0M | 37.1M | 25.3M | 27.2M | 19.5M | 12.4M | 13.3M | 11.2M | 9.1M |
| 銷售管理費用 | 4.7M | 4.7M | 4.7M | 4.5M | 4.6M | 5.1M | 5.0M | 4.8M | 5.3M | 5.2M | 4.9M | 4.3M |
| 營業利益 | −32.6M-22% | −21.1M-30% | −25.2M-22% | −26.5M+9% | −41.8M+135% | −30.4M+64% | −32.3M+101% | −24.4M+81% | −17.8M | −18.5M | −16.0M | −13.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | -443.8% | – | – | – |
| 稅後淨利 | −32.7M-20% | −20.7M-28% | −25.1M-16% | −26.5M+29% | −41.0M+175% | −28.8M+75% | −29.8M+130% | −20.5M+77% | −14.9M | −16.5M | −13.0M | −11.6M |
| 淨利率 | – | – | – | – | – | – | – | – | -371.4% | – | – | – |
| 稀釋 EPS | -0.45-34% | -0.33-31% | -0.40-20% | -0.44+29% | -0.68+172% | -0.48+71% | -0.50+108% | -0.34+21% | -0.25 | -0.28 | -0.24 | -0.28 |
| 稀釋股數 | 72.3M | 63.2M | 60.6M | 60.6M | 60.6M | 60.5M | 60.1M | 60.1M | 59.8M | 48.6M | 54.2M | 41.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 59.4M | 51.8M | 54.0M | 46.8M | 36.8M | 30.2M | 33.2M | 68.0M | 46.9M | 66.9M | 94.9M | 77.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 116M | 134M | 123M | 142M | 172M | 204M | 267M | 289M | 301M | 310M | 286M | 177M |
| 有息負債 | 11.9M | 16.9M | 22.4M | 27.1M | 29.9M | 29.5M | 29.7M | 29.4M | 30.2M | 29.9M | – | – |
| 總負債 | 58.7M | 46.2M | 52.4M | 49.0M | 54.8M | 49.0M | 49.8M | 45.0M | 38.9M | 43.2M | 6.1M | 8.5M |
| 股東權益 | 57.3M | 87.5M | 70.4M | 93.2M | 117M | 156M | 217M | 244M | 262M | 267M | 280M | 169M |
| 負債比 | 50.6% | 34.5% | 42.7% | 34.5% | 31.9% | 23.9% | 18.6% | 15.6% | 12.9% | 13.9% | 2.1% | 4.8% |
| 淨現金(現金 − 有息負債) | 47.5M | 34.9M | 31.6M | 19.8M | 6.9M | 631K | 3.5M | 38.6M | 16.7M | 37.0M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −24.1M-29% | – | – | – | −34.1M | – | – | −17.9M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 79K | – | – | 11K | – | – | – |
| 自由現金流 | – | −24.1M-29% | – | – | – | −34.2M | – | – | −17.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -446.2% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −121M | –% | -2.00 | −116M |
| FY2024 | – | – | −102M | –% | -1.71 | −86.2M |
| FY2023 | 10.8M | +351.1% | −52.4M | -485.3% | -1.08 | −43.1M |
| FY2022 | 2.4M | – | −42.9M | -1,791.6% | -1.06 | −35.3M |
| FY2021 | – | – | −101M | –% | -5.02 | −18.0M |
| FY2020 | – | – | −7.3M | –% | -17.48 | – |